Shanghai Rongtai Valuation
| 603579 Stock | 20.42 1.86 10.02% |
At this time, the company appears to be overvalued. Shanghai Rongtai Health has a current Real Value of USD15.72 per share. The regular price of the company is USD20.42. Our model measures the value of Shanghai Rongtai Health from inspecting the company fundamentals such as Operating Margin of 0.11 %, shares outstanding of 177.38 M, and Return On Equity of 0.0981 as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 1.6954 | Enterprise Value 3.3 B | Enterprise Value Ebitda 14.7408 | Price Sales 1.9106 | Trailing PE 17.4906 |
Overvalued
Today
Please note that Shanghai Rongtai's price fluctuation is not too volatile at this time. Calculation of the real value of Shanghai Rongtai Health is based on 3 months time horizon. Increasing Shanghai Rongtai's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shanghai Rongtai is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shanghai Stock. However, Shanghai Rongtai's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.42 | Real 15.72 | Hype 20.79 | Naive 20.33 |
The real value of Shanghai Stock, also known as its intrinsic value, is the underlying worth of Shanghai Rongtai Health Company, which is reflected in its stock price. It is based on Shanghai Rongtai's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shanghai Rongtai's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shanghai Rongtai Health helps investors to forecast how Shanghai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shanghai Rongtai more accurately as focusing exclusively on Shanghai Rongtai's fundamentals will not take into account other important factors: Shanghai Rongtai Cash |
|
Shanghai Rongtai Total Value Analysis
Shanghai Rongtai Health is presently forecasted to have takeover price of 3.29 B with market capitalization of 3.29 B, debt of 129.13 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shanghai Rongtai fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.29 B | 3.29 B | 129.13 M |
Shanghai Rongtai Investor Information
About 56.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.7. In the past many companies with similar price-to-book ratios have beat the market. Shanghai Rongtai Health last dividend was issued on the 16th of October 2024. The entity had 1.3:1 split on the 5th of June 2024. Shanghai Rongtai Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 235.8 M | 395.9 M |
|
| |||||
| Operating Income | 192.8 M | 248.1 M |
|
|
Shanghai Rongtai Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shanghai Rongtai has an asset utilization ratio of 54.8 percent. This suggests that the Company is making USD0.55 for each dollar of assets. An increasing asset utilization means that Shanghai Rongtai Health is more efficient with each dollar of assets it utilizes for everyday operations.Shanghai Rongtai Ownership Allocation
Shanghai Rongtai Health shows a total of 177.38 Million outstanding shares. Shanghai Rongtai Health maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Shanghai Rongtai Profitability Analysis
The company reported the revenue of 1.86 B. Net Income was 202.71 M with profit before overhead, payroll, taxes, and interest of 530.55 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shanghai Rongtai's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shanghai Rongtai and how it compares across the competition.
About Shanghai Rongtai Valuation
The stock valuation mechanism determines Shanghai Rongtai's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shanghai Rongtai. We calculate exposure to Shanghai Rongtai's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shanghai Rongtai's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 514.6 M | 511.4 M |
Shanghai Rongtai Quarterly Retained Earnings |
|
Complementary Tools for Shanghai Stock analysis
When running Shanghai Rongtai's price analysis, check to measure Shanghai Rongtai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rongtai is operating at the current time. Most of Shanghai Rongtai's value examination focuses on studying past and present price action to predict the probability of Shanghai Rongtai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rongtai's price. Additionally, you may evaluate how the addition of Shanghai Rongtai to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |